Evidence map›Paper›PMID 31641091›Full record

ArticlemBio2019

Human

Monique R Bennett, Jinhui Dong, Robin G Bombardi, Cinque Soto, Helen M Parrington, Rachel S Nargi, Clara T Schoeder, Marcus B Nagel, Kevin L Schey, Jens Meiler and 2 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Monique R Bennett *Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Jinhui Dong *Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Robin G BombardiVanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Cinque SotoVanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Helen M ParringtonDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Rachel S NargiVanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Clara T SchoederDepartment of Chemistry, Vanderbilt University, Nashville, Tennessee, USA.
Marcus B NagelDepartment of Biochemistry, Vanderbilt University, Nashville, Tennessee, USA.
Kevin L ScheyDepartment of Biochemistry, Vanderbilt University, Nashville, Tennessee, USA.
Jens MeilerDepartment of Biochemistry, Vanderbilt University, Nashville, Tennessee, USA.
Eric P SkaarDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA eric.skaar@vumc.org james.crowe@vumc.org.
James E CroweDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA eric.skaar@vumc.org james.crowe@vumc.org.ORCID 0000-0002-0049-1079
Vanderbilt University Medical Center · USVanderbilt University · US

Funding

Structure based design of antibodies and vaccinesU19AI117905 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MEILER, JENS · 2015 to 2019
$12.0M
Pathobiology of heme inducible transporters in Gram positive pathogensR01AI073843 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SKAAR, ERIC P · 2009 to 2025
$5.9M
Mechanism and function of heme-iron utilization in staphylococcal pathogenesisR01AI069233 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SKAAR, ERIC P · 2006 to 2020
$5.6M
Chemical Biology of Infectious Diseases (CBID) Training ProgramT32AI112541 · NIAID · VANDERBILT UNIVERSITY · PI Eric P Skaar · 2015 to 2026
$4.0M
Epitope-Based Design and Modified RNA Platform for Bivalent Marburgvirus VaccineR01AI141661 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BUKREYEV, ALEXANDER, CROWE, JAMES E · 2019 to 2023
$3.9M
NIAID NIH HHS R01 AI069233NIAID NIH HHS R01 AI073843NIAID NIH HHS R01 AI141661NIAID NIH HHS T32 AI112541NIAID NIH HHS U19 AI117905
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adaptive ImmunityAntibodies, MonoclonalCrystallography, X-RayHumansImmunity, HumoralProteomicsStaphylococcus aureusAntibodies, Monoclonaladaptive immunityantibody functionsantibody repertoirecomputer modelinghumoral immunitymonoclonal antibodiesproteomicsStaphylococcus aureusX-ray crystallography

Identifiers

PMID31641091
PMCPMC6805997
OpenAlexW2982213376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.